Cytogenetic polyclonality of breast carcinomas: association with clinico-pathological characteristics and outcome.

Genes Chromosomes Cancer 2011 Nov 24;50(11):930-9. Epub 2011 Aug 24.

Chromosome Laboratory, Department of Genetics and Molecular Medicine, Landspitali University Hospital, Reykjavík, Iceland.

Routinely used prognostic factors fail to predict clinical outcome in a significant proportion of breast cancer patients, implying that they can not detect some important biological characteristics. Chromosomal changes have been described in breast carcinomas for many years but their significance is not clear. We compared chromosomal changes with clinico-pathological characteristics and clinical outcome in 203 breast cancer patients with a follow-up of 9-18 years. Combining data from classical cytogenetics and flow cytometry revealed chromosomal abnormalities in 142 cases (70%). Of these, 51 (35.9%) contained two or more cytogenetically abnormal clones. Polyclonality was significantly associated with poor breast-cancer-specific survival (P = 0.03) within 5 years, independent of tumor size, lymph node metastases, and hormone receptors. Specific changes were similar to those previously described, but a new finding was a significant association between del 3p12p21 and poor survival. Polyclonality was significantly associated with TP53-mutations but not with a germline BRCA2 mutation. Less than one third of the polyclonal samples were identified by flow cytometry alone. Cytogenetic changes were detected in 17 out of 114 samples from non-tumorous tissue (15%), two of them identical with a clone in the corresponding tumor. Several samples contained clearly unrelated clones within the tumor and outside, implying either multifocal origin or early divergence. In conclusion, the common deletion on Chromosome 3p12p21 was associated with poor clinical outcome. Chromosomal polyclonality is common in breast carcinomas and predicts poor survival. Polyclonality was poorly detected by one-sample flow cytometry. Multiple sampling might improve the detection rate.

Download full-text PDF

Source
http://dx.doi.org/10.1002/gcc.20915DOI Listing
November 2011
2 Reads

Publication Analysis

Top Keywords

clinical outcome
12
flow cytometry
12
breast carcinomas
12
chromosomal changes
8
changes described
8
polyclonality associated
8
poor survival
8
breast cancer
8
cancer patients
8
clinico-pathological characteristics
8
survival polyclonality
8
associated poor
8
breast
5
tumor size
4
abnormalities 142
4
poor clinical
4
conclusion common
4
independent tumor
4
clone corresponding
4
size lymph
4

References

(Supplied by CrossRef)
Prognostic significance of nuclear DNA content in mammary adenocarcinomas in humans
Auer et al.
Cancer Res 1984
MYC amplification and TERT expression in breast tumor progression
Bodvarsdottir et al.
Cancer Genet Cytogenet 2007b
Hypoploidy defines patients with poor prognosis in breast cancer
Chavez-Uribe et al.
Oncol Rep 2007

Similar Publications